We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Resistance to a widely used flu drug is spreading among strains of the bird flu virus in Asia, according to a group of US-based researchers, while another group warns that even less harmful strains of the virus can jump to humans.

Both findings could have important implications for the widely predicted potential flu pandemic that could kill millions worldwide (see Time to prepare for bird flu pandemic 'running out').

A team led by Robert Webster at St Jude Children's Research Hospital in Memphis, United States, analysed genetic data from various strains of the bird flu virus collected in North America and South-East Asia between 1991 and 2004.

They found that H5 and H9 viruses resistant to amantadine, a drug used to treat human influenza, were becoming more common in Asia, especially in China.

By contrast, samples of the same viruses found in North America could still be treated with the drug.

A subtype of the H5 strain, known as H5N1, has killed 57 people in South-East Asia since late 2003. Tens of millions of chickens and other poultry have been destroyed in an effort to prevent the disease spreading.

Webster's team says drug resistance could be spreading in Asia because farmers are treating chickens with amantadine to stop the birds being infected with H5N1 (see Chinese farmers 'must not give human drug to poultry').

Using human flu drugs to treat chickens in this way is raising concern among scientists, as it could favour the emergence of drug resistant viruses that are even harder to treat, either in birds or humans.

Although the H5N1 bird flu strain can infect people, no cases of person-to-person transmission have yet been confirmed. In theory, however, once inside a human body, the virus could swap genetic material with human flu strains, forming a 'superstrain' that would create a global influenza pandemic.

So far, scientists have been tracking only highly dangerous strains of the bird flu virus, such H5N1, for signs that they could mutate into a form that can spread rapidly between people.

But in separate research, Isabella Donatelli at the Istituto Superiore di Sanità in Rome, Italy, and colleagues have shown for the first time that less dangerous strains can also infect people.

In an article published online in The Journal of Infectious Diseases, Donatelli's team says that their findings show how important it is for infectious disease specialists to monitor outbreaks of even the less harmful bird flu strains.

The team, whose results came from tests in people working on poultry farms with bird flu outbreaks, advise that all poultry workers should be vaccinated routinely.

But an accompanying editorial — written by Frederick Hayden of the University of Virginia, United States and Alice Croisier of the World Health Organization – says that in developing countries where people have little access to vaccines, people should be better educated about food and water hygiene, as well as poultry handling. .

Link to full article by Donatelli and colleagues

Link to editorial by Hayden and Croisier


Virology doi 10.1016/j.virol.2005.07.003 (2005) [Webster and colleagues]
The Journal of Infectious Diseases 192 (2005) [Donatelli and colleagues]

Related topics